
IRWD
USDIronwood Pharmaceuticals Inc. Class A Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.810
High
$1.890
Low
$1.760
Volume
0.59M
Company Fundamentals
Market Cap
303.8M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
1.39M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
– LINZESS® (Iinaclotide) U.S. net sales of $248 million in Q2 2025; EUTRx demand growth of 10% year-over-year – – Plans to align with FDA on confirmatory Phase 3 trial design in Q4 2025 – – Progressing
Related Stocks
RFL
Rafael Holdings Inc.
MEIP
MEI Pharma Inc.
NAC
Nuveen California Quality Municipal Income Fund
BWBBP
Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
CRGX
CARGO Therapeutics Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.